Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Synthesis and highly potent anti-inflammatory activity of licofelone- and ketorolac-based 1-arylpyrrolizin-3-ones.

Madrigal DA, Escalante CH, Gutiérrez-Rebolledo GA, Cristobal-Luna JM, Gómez-García O, Hernández-Benitez RI, Esquivel-Campos AL, Pérez-Gutiérrez S, Chamorro-Cevallos GA, Delgado F, Tamariz J.

Bioorg Med Chem. 2019 Oct 15;27(20):115053. doi: 10.1016/j.bmc.2019.115053. Epub 2019 Aug 20.

PMID:
31471100
2.

Enantiopure 4-oxazolin-2-ones and 4-methylene-2-oxazolidinones as chiral building blocks in a divergent asymmetric synthesis of heterocycles.

Santoyo BM, González-Romero C, Zárate-Zárate D, Hernández-Benitez RI, Pelayo V, Barrera E, Escalante CH, Fuentes-Benites A, Martínez-Morales G, López J, Vázquez MA, Delgado F, Jiménez-Vázquez HA, Tamariz J.

Chirality. 2019 Sep;31(9):719-749. doi: 10.1002/chir.23109. Epub 2019 Jul 18.

PMID:
31318100
3.

Occurrence of putative endornaviruses in non-cultivated plant species in South Louisiana.

Herschlag R, Escalante C, de Souto ER, Khankhum S, Okada R, Valverde RA.

Arch Virol. 2019 Jul;164(7):1863-1868. doi: 10.1007/s00705-019-04270-5. Epub 2019 May 7.

PMID:
31065853
4.

Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.

Dcona MM, Damle PK, Zarate-Perez F, Morris BL, Nawaz Z, Dennis MJ, Deng X, Korwar S, Singh SJ, Ellis KC, Royer WE, Bandyopadhyay D, Escalante C, Grossman SR.

Mol Pharmacol. 2019 Jul;96(1):99-108. doi: 10.1124/mol.118.114363. Epub 2019 Apr 29.

PMID:
31036695
5.

Nitrosative stress sensing in Porphyromonas gingivalis: structure of and heme binding by the transcriptional regulator HcpR.

Belvin BR, Musayev FN, Burgner J, Scarsdale JN, Escalante CR, Lewis JP.

Acta Crystallogr D Struct Biol. 2019 Apr 1;75(Pt 4):437-450. doi: 10.1107/S205979831900264X. Epub 2019 Apr 5.

PMID:
30988260
6.

Enormous haemangioma of the liver.

Zerpa R, Abdelghani EH, Iliescu G, Escalante C.

BMJ Case Rep. 2019 Mar 31;12(3). pii: e226983. doi: 10.1136/bcr-2018-226983.

PMID:
30936329
7.

A pilot study of brexpiprazole for bipolar depression.

Brown ES, Khaleghi N, Van Enkevort E, Ivleva E, Nakamura A, Holmes T, Mason BL, Escalante C.

J Affect Disord. 2019 Apr 15;249:315-318. doi: 10.1016/j.jad.2019.02.056. Epub 2019 Feb 19.

PMID:
30802696
8.

Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.

Escalante CP, Chisolm S, Song J, Richardson M, Salkeld E, Aoki E, Garcia-Manero G.

Cancer Med. 2019 Feb;8(2):543-553. doi: 10.1002/cam4.1953. Epub 2019 Jan 11.

9.

A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline in Patients with Alcohol Use Disorder.

Brown ES, Van Enkevort E, Kulikova A, Escalante C, Nakamura A, Ivleva EI, Holmes T.

Alcohol Clin Exp Res. 2019 Feb;43(2):317-323. doi: 10.1111/acer.13928. Epub 2018 Dec 24.

PMID:
30457668
10.

Genomic sequence of a novel endornavirus from Phaseolus vulgaris and occurrence in mixed infections with two other endornaviruses.

Okada R, Alcalá-Briseño RI, Escalante C, Sabanadzovic S, Valverde RA.

Virus Res. 2018 Sep 15;257:63-67. doi: 10.1016/j.virusres.2018.09.005. Epub 2018 Sep 12.

PMID:
30218691
11.

Exchange of functional domains between a bacterial conjugative relaxase and the integrase of the human adeno-associated virus.

Agúndez L, Zárate-Pérez F, Meier AF, Bardelli M, Llosa M, Escalante CR, Linden RM, Henckaerts E.

PLoS One. 2018 Jul 17;13(7):e0200841. doi: 10.1371/journal.pone.0200841. eCollection 2018.

12.

An effort expenditure perspective on cancer-related fatigue.

Lacourt TE, Vichaya EG, Escalante C, Manzullo EF, Gunn B, Hess KR, Heijnen CJ, Dantzer R.

Psychoneuroendocrinology. 2018 Oct;96:109-117. doi: 10.1016/j.psyneuen.2018.06.009. Epub 2018 Jun 9.

13.

Handoff Tool Enabling Standardized Transitions Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center.

Gonzalez CE, Brito-Dellan N, Banala SR, Rubio D, Ait Aiss M, Rice TW, Chen K, Bodurka DC, Escalante CP.

Am J Med Qual. 2018 Nov/Dec;33(6):629-636. doi: 10.1177/1062860618776096. Epub 2018 May 21.

PMID:
29779398
14.

Health care service utilization of documented and undocumented hired farmworkers in the U.S.

Luo T, Escalante CL.

Eur J Health Econ. 2018 Sep;19(7):923-934. doi: 10.1007/s10198-017-0939-x. Epub 2017 Nov 16.

PMID:
29147814
15.

Cancer-Related Fatigue in Cancer Survivorship.

Ebede CC, Jang Y, Escalante CP.

Med Clin North Am. 2017 Nov;101(6):1085-1097. doi: 10.1016/j.mcna.2017.06.007. Epub 2017 Aug 25. Review.

PMID:
28992856
16.

Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects.

Ibi D, de la Fuente Revenga M, Kezunovic N, Muguruza C, Saunders JM, Gaitonde SA, Moreno JL, Ijaz MK, Santosh V, Kozlenkov A, Holloway T, Seto J, García-Bea A, Kurita M, Mosley GE, Jiang Y, Christoffel DJ, Callado LF, Russo SJ, Dracheva S, López-Giménez JF, Ge Y, Escalante CR, Meana JJ, Akbarian S, Huntley GW, González-Maeso J.

Nat Neurosci. 2017 Sep;20(9):1247-1259. doi: 10.1038/nn.4616. Epub 2017 Aug 7.

17.

Analysis of Replicative Intermediates of Adeno-associated Virus through Hirt Extraction and Southern Blotting.

Bardelli M, Zarate-Perez F, Agundez L, Jolinon N, Michael Linden R, Escalante CR, Henckaerts E.

Bio Protoc. 2017 May 5;7(9). pii: e2271. doi: 10.21769/BioProtoc.2271.

18.

Determination of Adeno-associated Virus Rep DNA Binding Using Fluorescence Anisotropy.

Zarate-Perez F, Santosh V, Bardelli M, Agundez L, Linden RM, Henckaerts E, Escalante CR.

Bio Protoc. 2017 Mar 20;7(6). pii: e2194.

19.
20.

Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans.

Escalante CP, Gladish GW, Qiao W, Zalpour A, Assylbekova B, Gao S, Olejeme KA, Richardson MN, Suarez-Almazor ME.

Support Care Cancer. 2017 May;25(5):1571-1577. doi: 10.1007/s00520-016-3559-6. Epub 2017 Jan 9.

PMID:
28070669
21.

Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial.

Lu H, Champlin RE, Popat U, Pundole X, Escalante CP, Wang X, Qiao W, Murphy WA, Gagel RF.

Bonekey Rep. 2016 Oct 19;5:843. doi: 10.1038/bonekey.2016.72. eCollection 2016.

22.

Meta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents.

Escalante CP, Chang YC, Liao K, Rouleau T, Halm J, Bossi P, Bhadriraju S, Brito-Dellan N, Sahai S, Yusuf SW, Zalpour A, Elting LS; Epidemiology Section of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer, 2013.

Support Care Cancer. 2016 Sep;24(9):4057-74. doi: 10.1007/s00520-016-3310-3. Epub 2016 Jun 25. Review.

PMID:
27344327
23.

Development of Teleological Explanations in Peruvian Quechua-Speaking and U.S. English-Speaking Preschoolers and Adults.

Sánchez Tapia I, Gelman SA, Hollander MA, Manczak EM, Mannheim B, Escalante C.

Child Dev. 2016 May;87(3):747-58. doi: 10.1111/cdev.12497.

24.

Identification of a Functionally Relevant Adeno-Associated Virus Rep68 Oligomeric Interface.

Bardelli M, Zárate-Pérez F, Agúndez L, Linden RM, Escalante CR, Henckaerts E.

J Virol. 2016 Jul 11;90(15):6612-6624. doi: 10.1128/JVI.00356-16. Print 2016 Aug 1.

25.

Functional architecture of the Reb1-Ter complex of Schizosaccharomyces pombe.

Jaiswal R, Choudhury M, Zaman S, Singh S, Santosh V, Bastia D, Escalante CR.

Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):E2267-76. doi: 10.1073/pnas.1525465113. Epub 2016 Mar 28.

26.

Update of Targeted Therapy-Induced Hypertension: Basics for Non-Oncology Providers.

Escalante CP, Lu M, Marten CA.

Curr Hypertens Rev. 2016;12(2):112-20. Review.

PMID:
26931476
27.

Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain.

Remesh SG, Santosh V, Escalante CR.

J Biol Chem. 2015 Nov 13;290(46):27779-90. doi: 10.1074/jbc.M115.678789. Epub 2015 Sep 24.

28.

Structural Insights into the Assembly of the Adeno-associated Virus Type 2 Rep68 Protein on the Integration Site AAVS1.

Musayev FN, Zarate-Perez F, Bishop C, Burgner JW 2nd, Escalante CR.

J Biol Chem. 2015 Nov 13;290(46):27487-99. doi: 10.1074/jbc.M115.669960. Epub 2015 Sep 14.

29.

Structural Studies of AAV2 Rep68 Reveal a Partially Structured Linker and Compact Domain Conformation.

Musayev FN, Zarate-Perez F, Bardelli M, Bishop C, Saniev EF, Linden RM, Henckaerts E, Escalante CR.

Biochemistry. 2015 Sep 29;54(38):5907-19. doi: 10.1021/acs.biochem.5b00610. Epub 2015 Sep 14.

30.

Cancer-Related Fatigue, Version 2.2015.

Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39.

31.

ROS-induced nanotherapeutic approach for ovarian cancer treatment based on the combinatorial effect of photodynamic therapy and DJ-1 gene suppression.

Schumann C, Taratula O, Khalimonchuk O, Palmer AL, Cronk LM, Jones CV, Escalante CA, Taratula O.

Nanomedicine. 2015 Nov;11(8):1961-70. doi: 10.1016/j.nano.2015.07.005. Epub 2015 Jul 31.

PMID:
26238076
32.

Erratum to: The biology of cancer-related fatigue: a review of the literature.

Saligan LN, Olson K, Filler K, Larkin D, Cramp F, Yennurajalingam S, Escalante CP, del Giglio A, Kober KM, Kamath J, Palesh O, Mustian K; Multinational Association of Supportive Care in Cancer Fatigue StudyGroup–Biomarker Working Group.

Support Care Cancer. 2015 Sep;23(9):2853. doi: 10.1007/s00520-015-2815-5. No abstract available.

PMID:
26081598
33.

A multilaboratory comparison of calibration accuracy and the performance of external references in analytical ultracentrifugation.

Zhao H, Ghirlando R, Alfonso C, Arisaka F, Attali I, Bain DL, Bakhtina MM, Becker DF, Bedwell GJ, Bekdemir A, Besong TM, Birck C, Brautigam CA, Brennerman W, Byron O, Bzowska A, Chaires JB, Chaton CT, Cölfen H, Connaghan KD, Crowley KA, Curth U, Daviter T, Dean WL, Díez AI, Ebel C, Eckert DM, Eisele LE, Eisenstein E, England P, Escalante C, Fagan JA, Fairman R, Finn RM, Fischle W, de la Torre JG, Gor J, Gustafsson H, Hall D, Harding SE, Cifre JG, Herr AB, Howell EE, Isaac RS, Jao SC, Jose D, Kim SJ, Kokona B, Kornblatt JA, Kosek D, Krayukhina E, Krzizike D, Kusznir EA, Kwon H, Larson A, Laue TM, Le Roy A, Leech AP, Lilie H, Luger K, Luque-Ortega JR, Ma J, May CA, Maynard EL, Modrak-Wojcik A, Mok YF, Mücke N, Nagel-Steger L, Narlikar GJ, Noda M, Nourse A, Obsil T, Park CK, Park JK, Pawelek PD, Perdue EE, Perkins SJ, Perugini MA, Peterson CL, Peverelli MG, Piszczek G, Prag G, Prevelige PE, Raynal BD, Rezabkova L, Richter K, Ringel AE, Rosenberg R, Rowe AJ, Rufer AC, Scott DJ, Seravalli JG, Solovyova AS, Song R, Staunton D, Stoddard C, Stott K, Strauss HM, Streicher WW, Sumida JP, Swygert SG, Szczepanowski RH, Tessmer I, Toth RT 4th, Tripathy A, Uchiyama S, Uebel SF, Unzai S, Gruber AV, von Hippel PH, Wandrey C, Wang SH, Weitzel SE, Wielgus-Kutrowska B, Wolberger C, Wolff M, Wright E, Wu YS, Wubben JM, Schuck P.

PLoS One. 2015 May 21;10(5):e0126420. doi: 10.1371/journal.pone.0126420. eCollection 2015.

34.

The biology of cancer-related fatigue: a review of the literature.

Saligan LN, Olson K, Filler K, Larkin D, Cramp F, Yennurajalingam S, Escalante CP, del Giglio A, Kober KM, Kamath J, Palesh O, Mustian K; Multinational Association of Supportive Care in Cancer Fatigue Study Group-Biomarker Working Group.

Support Care Cancer. 2015 Aug;23(8):2461-78. doi: 10.1007/s00520-015-2763-0. Epub 2015 May 15. Review. Erratum in: Support Care Cancer. 2015 Sep;23(9):2853. Sriram, Yennu [corrected to Yennurajalingam, Sriram].

35.

High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report.

Yennurajalingam S, Reddy A, Tannir NM, Chisholm GB, Lee RT, Lopez G, Escalante CP, Manzullo EF, Frisbee Hume S, Williams JL, Cohen L, Bruera E.

Integr Cancer Ther. 2015 Sep;14(5):419-27. doi: 10.1177/1534735415580676. Epub 2015 Apr 14.

PMID:
25873296
36.

Crystallization and preliminary X-ray characterization of the eukaryotic replication terminator Reb1-Ter DNA complex.

Jaiswal R, Singh SK, Bastia D, Escalante CR.

Acta Crystallogr F Struct Biol Commun. 2015 Apr;71(Pt 4):414-8. doi: 10.1107/S2053230X15004112. Epub 2015 Mar 20.

37.

Ongoing Screening and Treatment to Potentially Reduce Tyrosine Kinase Inhibitor-Related Fatigue in Renal Cell Carcinoma.

Anand D, Escalante CP.

J Pain Symptom Manage. 2015 Jul;50(1):108-17. doi: 10.1016/j.jpainsymman.2015.02.007. Epub 2015 Feb 18. Review.

PMID:
25701692
38.

Adeno-associated virus Rep represses the human integration site promoter by two pathways that are similar to those required for the regulation of the viral p5 promoter.

Dutheil N, Smith SC, Agúndez L, Vincent-Mistiaen ZI, Escalante CR, Linden RM, Henckaerts E.

J Virol. 2014 Aug;88(15):8227-41. doi: 10.1128/JVI.00412-14. Epub 2014 May 14.

39.

Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation.

Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Schnipper HH, Lacchetti C, Ligibel JA, Lyman GH, Ogaily MS, Pirl WF, Jacobsen PB; American Society of Clinical Oncology.

J Clin Oncol. 2014 Jun 10;32(17):1840-50. doi: 10.1200/JCO.2013.53.4495. Epub 2014 Apr 14.

40.

A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients.

Escalante CP, Meyers C, Reuben JM, Wang X, Qiao W, Manzullo E, Alvarez RH, Morrow PK, Gonzalez-Angulo AM, Wang XS, Mendoza T, Liu W, Holmes H, Hwang J, Pisters K, Overman M, Cleeland C.

Cancer J. 2014 Jan-Feb;20(1):8-14. doi: 10.1097/PPO.0000000000000018.

41.

Chronic conditions and health status in older cancer survivors.

Holmes HM, Nguyen HT, Nayak P, Oh JH, Escalante CP, Elting LS.

Eur J Intern Med. 2014 Apr;25(4):374-8. doi: 10.1016/j.ejim.2013.12.003. Epub 2014 Jan 2.

PMID:
24389373
42.

Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis.

Elting LS, Chang YC, Parelkar P, Boers-Doets CB, Michelet M, Hita G, Rouleau T, Cooksley C, Halm J, Vithala M, Bossi P, Escalante C, Brennan MT; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO).

Support Care Cancer. 2013 Nov;21(11):3243-54. doi: 10.1007/s00520-013-1821-8. Epub 2013 May 2. Review.

PMID:
23636648
43.

Oligomeric properties of adeno-associated virus Rep68 reflect its multifunctionality.

Zarate-Perez F, Mansilla-Soto J, Bardelli M, Burgner JW 2nd, Villamil-Jarauta M, Kekilli D, Samso M, Linden RM, Escalante CR.

J Virol. 2013 Jan;87(2):1232-41. doi: 10.1128/JVI.02441-12. Epub 2012 Nov 14.

44.

A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes.

Glasmacher E, Agrawal S, Chang AB, Murphy TL, Zeng W, Vander Lugt B, Khan AA, Ciofani M, Spooner CJ, Rutz S, Hackney J, Nurieva R, Escalante CR, Ouyang W, Littman DR, Murphy KM, Singh H.

Science. 2012 Nov 16;338(6109):975-80. doi: 10.1126/science.1228309. Epub 2012 Sep 13.

45.

The interdomain linker of AAV-2 Rep68 is an integral part of its oligomerization domain: role of a conserved SF3 helicase residue in oligomerization.

Zarate-Perez F, Bardelli M, Burgner JW 2nd, Villamil-Jarauta M, Das K, Kekilli D, Mansilla-Soto J, Linden RM, Escalante CR.

PLoS Pathog. 2012;8(6):e1002764. doi: 10.1371/journal.ppat.1002764. Epub 2012 Jun 14.

46.

A randomized controlled trial of an intensive insulin regimen in patients with hyperglycemic acute lymphoblastic leukemia.

Vu K, Busaidy N, Cabanillas ME, Konopleva M, Faderl S, Thomas DA, O'Brien S, Broglio K, Ensor J, Escalante C, Andreeff M, Kantarjian H, Lavis V, Yeung SC.

Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):355-62. doi: 10.1016/j.clml.2012.05.004. Epub 2012 Jun 1.

47.

Artemis C-terminal region facilitates V(D)J recombination through its interactions with DNA Ligase IV and DNA-PKcs.

Malu S, De Ioannes P, Kozlov M, Greene M, Francis D, Hanna M, Pena J, Escalante CR, Kurosawa A, Erdjument-Bromage H, Tempst P, Adachi N, Vezzoni P, Villa A, Aggarwal AK, Cortes P.

J Exp Med. 2012 May 7;209(5):955-63. doi: 10.1084/jem.20111437. Epub 2012 Apr 23.

48.

A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer.

Levine MN, Gu C, Liebman HA, Escalante CP, Solymoss S, Deitchman D, Ramirez L, Julian J.

J Thromb Haemost. 2012 May;10(5):807-14. doi: 10.1111/j.1538-7836.2012.04693.x.

49.

Role of factor xa inhibitors in cancer-associated thrombosis: any new data?

Zalpour A, Kroll MH, Afshar-Kharghan V, Yusuf SW, Escalante C.

Adv Hematol. 2011;2011:196135. doi: 10.1155/2011/196135. Epub 2011 Oct 15.

50.

Vascular endothelial growth factor inhibitor-induced hypertension: basics for primary care providers.

Escalante CP, Zalpour A.

Cardiol Res Pract. 2011;2011:816897. doi: 10.4061/2011/816897. Epub 2011 May 10.

Supplemental Content

Loading ...
Support Center